Experiments in a mouse model on the therapeutic potential of the anti-CTLA-4 antibody have shown that it may be an important tool to inhibit the progression of endometriosis by regulating the overproduction of CD4+ CD25+ Treg cells, a phenomenon repeatedly reported in the literature [175]. Here, CD4 is linked to endometriosis.